Literature DB >> 10829062

The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.

T Shishido1, T Akagi, T Ouchi, M M Georgescu, W Y Langdon, H Hanafusa.   

Abstract

The kinase activity of Abl is known to be regulated by a putative trans-acting inhibitor molecule interacting with the Src homology (SH) 3 domain of Abl. Here we report that the kinase-deficient Src (SrcKD) directly inhibits the tyrosine phosphorylation of Cbl and other cellular proteins by Abl. We found that both the SH2 and SH3 domains of SrcKD are necessary for the suppressor activity toward the Abl kinase phosphorylating Cbl. To suppress the Cbl phosphorylation by Abl, the interaction between the SH3 domain of SrcKD and Cbl is required. This interaction between SrcKD and Cbl is regulated by a closed structure of Cbl. The binding of Abl to the extreme carboxyl-terminal region of Cbl unmasks the binding site of SrcKD to Cbl. This results in a ternary complex that inhibits the Abl-mediated phosphorylation of Cbl by steric hindrance. These results illustrate a mechanism by which the enzymatically inactive Src can exert a biological function in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829062      PMCID: PMC18621          DOI: 10.1073/pnas.060030697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.

Authors:  T J Blake; M Shapiro; H C Morse; W Y Langdon
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

2.  Enzymatically inactive p60c-src mutant with altered ATP-binding site is fully phosphorylated in its carboxy-terminal regulatory region.

Authors:  R Jove; S Kornbluth; H Hanafusa
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

3.  Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.

Authors:  M C O'Brien; Y Fukui; H Hanafusa
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

4.  Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations.

Authors:  P L Schwartzberg; A M Stall; J D Hardin; K S Bowdish; T Humaran; S Boast; M L Harbison; E J Robertson; S P Goff
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

5.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.

Authors:  A M Pendergast; A J Muller; M H Havlik; R Clark; F McCormick; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor.

Authors:  M Bartkiewicz; A Houghton; R Baron
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.

Authors:  B J Mayer; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.

Authors:  C E Andoniou; C B Thien; W Y Langdon
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more
  4 in total

1.  Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.

Authors:  Philippe Soubeyran; Ana Barac; Iwona Szymkiewicz; Ivan Dikic
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Tyrosine phosphorylated c-Cbl regulates platelet functional responses mediated by outside-in signaling.

Authors:  Lorena Buitrago; Wallace Y Langdon; Archana Sanjay; Satya P Kunapuli
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

3.  Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1.

Authors:  Amy R Sanguinetti; Haiming Cao; Cynthia Corley Mastick
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

Review 4.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.